Ingevity (NGVT) Cash & Equivalents (2016 - 2025)
Ingevity (NGVT) has disclosed Cash & Equivalents for 11 consecutive years, with $78.1 million as the latest value for Q4 2025.
- Quarterly Cash & Equivalents rose 14.85% to $78.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.1 million through Dec 2025, up 14.85% year-over-year, with the annual reading at $78.1 million for FY2025, 14.85% up from the prior year.
- Cash & Equivalents for Q4 2025 was $78.1 million at Ingevity, down from $83.4 million in the prior quarter.
- The five-year high for Cash & Equivalents was $275.4 million in Q4 2021, with the low at $68.0 million in Q2 2023.
- Average Cash & Equivalents over 5 years is $127.7 million, with a median of $86.5 million recorded in 2023.
- The sharpest move saw Cash & Equivalents crashed 73.16% in 2022, then skyrocketed 60.36% in 2024.
- Over 5 years, Cash & Equivalents stood at $275.4 million in 2021, then plummeted by 72.15% to $76.7 million in 2022, then rose by 25.03% to $95.9 million in 2023, then fell by 29.09% to $68.0 million in 2024, then rose by 14.85% to $78.1 million in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods came in at $78.1 million, $83.4 million, and $76.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.